Key result
First-trimester pregnancy carries a ~20% prevalence of elevated NT-proBNP, exceeding later trimesters and nonpregnant women.
Why the study?
Physiologic changes in NT-proBNP across trimesters of pregnancy have not been well studied.
Does NT-proBNP vary by pregnancy status and trimester in adult women without cardiovascular disease?
Cross-Sectional (n=2,134)
Yes
Does NT-proBNP vary by pregnancy status and trimester in adult women without cardiovascular disease?
NT-proBNP levels are dynamically elevated in the first trimester of pregnancy compared to nonpregnant women and decrease by the third trimester, which should be considered when interpreting this biomarker in pregnant patients.
Answers are grounded in this paper and cite their sources.
May require trimester-adjusted NT-proBNP thresholds in pregnancy; leaves open need for longitudinal validation.
BACKGROUND: Physiologic changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP) across trimesters of pregnancy have not been well studied. OBJECTIVES: The authors aimed to measure NT-proBNP in adult women, by pregnancy status and trimester, in a nationally representative sample from the National Health and Nutrition Examination Survey 1999 to 2004. METHODS: We conducted a cross-sectional analysis of 2,134 women (546 pregnant) aged 20 to 40 years without a history of cardiovascular disease. RESULTS: Among pregnant women in the first trimester, the prevalence of elevated NT-proBNP (>125 pg/mL) was 20.0% (SE, 6.6%) compared to 2.4% (SE, 0.8%) among women in the third trimester and 8.0% among nonpregnant women. After adjustment for demographics and cardiovascular risk factors, NT-proBNP was 44% higher (absolute difference 26.4 [95% CI: 11.2-41.6] pg/mL) in the first trimester of pregnancy compared to nonpregnant women. Among pregnant women only, adjusted NT-proBNP was 46% lower (absolute difference -22.2 [95% CI: -36.9 to -7.5] pg/mL) in women in the third trimester compared to women in the first trimester. NT-proBNP was inversely associated with body mass index and with systolic blood pressure. CONCLUSIONS: Women in the first trimester of pregnancy had significantly higher NT-proBNP than those in the third trimester and compared to similarly aged nonpregnant women. The dynamic nature of NT-proBNP should be taken into consideration when ordering NT-proBNP lab tests in pregnant women.
No takes yet. Share an insight, caveat, or question.
Minhas et al. (2023) conducted a cross-sectional in Pregnancy (n=2,134). First trimester of pregnancy vs. Third trimester of pregnancy and nonpregnant women was evaluated on Elevated NT-proBNP (>125 pg/mL) (Absolute difference 26.4 pg/mL, 95% CI 11.2-41.6). Women in the first trimester of pregnancy had a higher prevalence of elevated NT-proBNP compared to those in the third trimester and nonpregnant women.
Synapse has enriched 10 related papers. Consider them for comparative context: